住院哮喘患者规范化管理的单中心10年经验分析
回顾性分析2008至2017年单中心2 207例次住院哮喘患者,哮喘住院占比从2008年的16.9%逐步降至2014至2017年的9.4%,急性加重住院占比从14.2%降至5.9%。规范化管理可减少住院和急性加重风险,应关注急性加重反复住院的危险因素。
要点
- 哮喘住院占比从2008年16.9%降至2014至2017年9.4%,急性加重住院占比从14.2%降至5.9%。
- 反复急性加重住院危险因素包括感染诱发、男性、年龄≥65岁、湿啰音、住院≥14天和有创机械通气。
- 3月和8月为急性加重入院高峰月,2月最低。
核心结论
- 哮喘规范化管理可显著减少哮喘患者住院次数及急性加重风险。
- 应评估并管理哮喘急性加重和反复住院的危险因素,以减少多次住院。
研究设计与样本
- 回顾性分析2008年1月1日至2017年12月31日北部战区总医院呼吸内科与变态反应疾病诊治中心住院的2 207例次哮喘患者临床资料。
主要发现
- 10年住院哮喘患者占同期住院患者的11.5%(2 207/19 134),2008年为16.9%(207/1 223),2009至2013年中位数13.2%(221/1 674),2014至2017年中位数9.4%(224/2 385)。
- 因哮喘急性加重入院1 553例,占同期住院患者的8.1%(1 553/19 134),2008年为14.2%(174/1 223),2009至2013年中位数9.7%(163/1 674),2014至2017年中位数5.9%(141/2 385)。
- 因哮喘共患疾病急性加重入院的患者占比2008年最低为15.9%(33/207),2009至2013年中位数25.8%(58/221),2014至2017年中位数37.0%(83/224)。
- 哮喘急性加重住院高峰月为3月(9.2%,150/1 628)和8月(9.7%,157/1 612),最低为2月(7.1%,101/1 423)。
- 反复急性加重住院(≥2次)危险因素:感染诱发(OR=2.006)、男性(OR=1.355)、年龄≥65岁(OR=1.364)、体检有湿啰音(OR=1.762)、住院天数≥14 d(OR=1.892)、有创机械通气(OR=1.798)。
关键数值与推荐
- 哮喘反复住院患者人均费用(16 219±16 628)元(n=681),单次住院患者(13 752±20 692)元(n=1 526),差异有统计学意义(P<0.05)。
- 哮喘急性加重反复住院患者人均费用(13 933±13 036)元(n=479),单次急性加重住院患者(11 208±13 853)元(n=1 074),差异有统计学意义(P<0.05)。
临床怎么用
- 对住院哮喘患者应评估急性加重反复住院危险因素,包括感染、男性、高龄、湿啰音、长住院和有创机械通气。
- 关注3月和8月急性加重高峰月,加强季节性管理。
- 规范化管理可降低住院率和急性加重风险。
局限性
- 本研究为单中心回顾性分析,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To analyze the outcome of standardized management on the hospitalized asthmatic patients in the past 10 years in a single center. Methods: Clinical data of 2 207 asthmatic patients, who were hospitalized in the Center of Respiratory Medicine and Allergic Diseases, the General Hospital of Northern Military District from January 1, 2008 to December 31, 2017, was retrospectively collected and analyzed. Results: Asthmatic in-patients accounted for 11.5% of total hospitalized patients(2 207/19 134) over the 10-year study period. The highest percentage of asthmatic patients over the total hospitalized patients (16.9%, 207/1 223) was in the year 2008, and it was gradually reduced from 2009 through 2017: a median of 13.2% (221/1 674) from 2009 to 2013 with 3.7% decrease, and a median of 9.4% (224/2 385) from 2014 to 2017 with 7.5% decrease. There was a significant difference in the percentages between the year of 2008 (16.9%) and the years from 2009 through 2017 (P<0.05). Over the 10-year study period, 69.1% (1 526/2 207) of the asthmatic in-patients were hospitalized only once, 13.3% (294/2 207) were twice, and 3.8% (85/2 207) were hospitalized more than twice. Totally 1,553 patients were hospitalized with acute asthmatic attack, which accounted for 8.1% (1 553/19 134) of the total in-patient number over the 10 years, and 14.2% (174/1 223) of which was in the year 2008, while 9.7% (163/1 674) was in the years from 2009 through 2013 with a decrease of 4.5% from 2008, and 5.9% (141/2 385) was in 2014 through 2017 with a decrease of 8.3% from 2008. The differences between the 2008 incidence and that of 2009-2013 or 2014-2017 were statistically significant (P<0.05). However, the incidence of acute exacerbation of comorbid conditions was lowest in 2008 (15.9%, 33/207), while it was 25.8% (58/221) from 2009 to 2013 with an increase of 9.9% from 2008, and 37.0% (83/224) from 2013 to 2017 with an increase of 21.1% compared to 2008. Asthmatic hospitalization peaked in March (9.2%, 150/1 628) and August (9.7%, 157/1 612), respectively, while it was lowest in February (7.1%,101/1 423). The difference between the peak months (March and August) and February was statistically significant (P<0.05), while there was no significant difference between February and the rest of months (P>0.05). When the risk factors for acute asthmatic attack was analyzed by grouping single-time attack (n=1 074) versus multiple-time attack (hospitalized ≥ 2 times, n=479), we found the following risk factors were significant: airway infection (OR=2.006), male (OR=1.355), age ≥ 65 years old (OR=1.364), wet rales on physical examination (OR=1.762), hospitalization ≥ 14 days (OR=1.892), and invasive mechanical ventilation (OR=1.798). In addition, there were significant differences in per capital cost comparison between the following pairs (P<0.05): multiple-time (16 219±16 628, n=681) vs single-time asthmatic hospitalization (13 752±20 692, n=1 526), multiple-time (13 933±13 036, n=479) vs single-time hospitalization with acute asthmatic attack (11 208±13 853, n=1 074), multi-time asthmatic hospitalization (n=681) vs multi-time hospitalization with acute asthmatic attack (n=479), and single-time asthmatic hospitalization (n=1 526) vs single-time hospitalization with acute asthmatic attack (n=1 074). Conclusions: Standardized management of asthma could significantly reduce the risk of hospitalization as well as acute asthmatic attack. Findings of the current study suggested that risk factors for acute and recurrent asthmatic attack should be assessed and managed efficiently in order to reduce incidence of multiple hospitalization for asthma. 目的: 分析规范化支气管哮喘(哮喘)管理对住院哮喘患者的效果。 方法: 回顾性分析2008年1月1日到2017年12月31日在北部战区总医院呼吸内科与变态反应疾病诊治中心住院的2 207例次哮喘患者的临床资料。 结果: 10年住院哮喘患者占同期住院患者的11.5%(2 207/19 134),2008年最高(16.9%,207/1 223),之后下降,2009—2013年中位数为13.2%(221/1 674),2014—2017年中位数为9.4%(224/2 385),2009—2017年与2008年比较差异均有统计学意义(均P<0.05)。10年期间住院1次的哮喘患者占69.1%(1 526/2 207),住院2次占13.3%(294/2 207),住院2次以上占3.8%(85/2 207);因哮喘急性加重入院患者1 553例,占同期住院患者的8.1%(1 553/19 134),2008年最高,为14.2%(174/1 223),之后下降,2009—2013年中位数为9.7%(163/1 674),2014—2017年中位数为5.9%(141/2 385),2009—2017年与2008年比较差异均有统计学意义(均P<0.05)。因哮喘共患疾病急性加重入院的患者占所有哮喘患者百分比2008年最低,为15.9%(33/207),总体呈现增加趋势,2009—2013年中位数为25.8%(58/221),2014—2017年中位数为37.0%(83/224)。哮喘急性加重住院月份:占9.2%(150/1 628)的3月和占9.7%(157/1 612)的8月是哮喘急性加重入院高峰月,和患者入院最少占7.1%(101/1 423)的2月进行比较,差异有统计学意义(P<0.05);其他月份与2月比,差异无统计学意义(P<0.05);哮喘急性加重住院1次占69.2%(1 074/1 553)。将哮喘急性加重住院患者分为多次组(住院≥2次,479例)和1次组(1 074例),发现多次组危险因素为感染诱发(OR:2.006),男性(OR:1.355),年龄≥ 65岁(OR:1.364),体检有湿啰音(OR:1.762),住院天数≥14 d(OR:1.892)和行有创机械通气(OR:1.798)。哮喘反复住院患者的人均费用为(16 219±16 628,681例)元,与单次住院患者人均费用[(13 752±20 692,n=1 526)元]比较、哮喘急性加重反复住院患者的人均费用为(13 933±13 036,n=479)元,与单次哮喘急性加重住院患者人均费用[(11 208±13 853,1 074例)元]比较、哮喘反复住院患者(681例)和哮喘急性加重反复住院患者(479例)比较、哮喘单次住院患者(1 526例)与哮喘急性加重单次住院患者(1 074例)比较,差异均有统计学意义(P<0.05)。 结论: 哮喘规范化管理可减少哮喘患者住院次数,哮喘规范化管理应关注哮喘急性加重反复住院的危险因素。.
引用
- Xie H, Chen P, Zhang ZY, et al. [Analysis on the standardized management of hospitalized asthmatic patients: a single center 10-years experience]. Zhonghua Jie He He Hu Xi Za Zhi. 2019. PMID: 30845394. doi:10.3760/cma.j.issn.1001-0939.2019.03.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。